Get Premium to unlock powerful stock data
Eagle Pharmaceuticals Inc logo

Eagle Pharmaceuticals Inc $ 47.42 -1.18 (-2.43%)

Volume:
80,779
Avg Vol (1m):
76,153
Market Cap $:
612.38 Mil
Enterprise Value $:
559.61 Mil
PE Ratio:
118.54
PB Ratio:
3.32
Warning! GuruFocus has detected 1 Severe warning sign with EGRX. Click here to check it out.
Also Trade In: Germany
EMBED
5D 3M YTD 1Y 3Y 5Y 10Y All 10Y -%
Above Low: +NaN%
Below High: NaN%
Peers

Eagle Pharmaceuticals Inc Stock Institutional Ownership and Insider Ownership -

12.91
(Mil)
Shares Outstanding
75.69%
9.91 (Mil)
Institutional Ownership
13.77%
1.82 (Mil)
Insider Ownership
60.84%
7.8545 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Eagle Pharmaceuticals Inc. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of Eagle Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders